- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Weekly Investor Report
Linde India Limited · Basic Materials · Specialty Chemicals
Mixed setup
The weekly trend is not active. Price is 2.4% above the Trend Line and sits at 60.6% of its 52-week range. The latest completed week returned 5.2%, after a 1.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 59/100.
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 42.78% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 2.4% above the Trend Line and sits at 60.6% of its 52-week range. The latest completed week returned 5.2%, after a 1.3% four-week move.
52-week price path
Price vs Trend Line and Fair ValueIs real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price directionActivity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
12-week confirmation
No recent accumulation markers. No reversal markers.
Is performance persistent—and is the stock leading?
Performance is 1.3% over four weeks, -3.3% over 12 weeks, and 11.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Activity pressure vs relative leadership
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 122.2x Price divided by trailing earnings.
- Price / sales
- 24.5x Market value relative to trailing revenue.
- EV / EBITDA
- 66.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 78.6% Gross profit retained from each unit of revenue.
- Operating margin
- 24.3% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.8% Free cash flow generated from revenue.
- Return on invested capital
- 10.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 1.8% Latest one-year revenue growth.
- EPS growth
- 20.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.2% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.0x Balance-sheet debt relative to operating cash earnings.
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
No recent insider transactions are stored for this company.
Weighted news tone is positive across 25 relevant articles.
6 positive · 17 neutral · 2 negativeActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signalWhat can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
Shape of recent returns
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
Four-week leaders
Four-week leaders
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis61/100Latest 12-week confirmation: trend 10/12, activity pressure 3/12, relative leadership 12/12.
Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 42.78%Next-week expectancy is negative with a 42.78% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors45/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 43 SVQF10/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1420.5 of 1580 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment59/100Weighted news tone is positive across 25 relevant articles.
Linde India Shares Gain 2.04% in Early Trade, Among Top Gainers on Nifty Midcap 150 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 7,112 INR | 5.2% | 6,949 INR | 6,704 INR | -0.78 | 8.27 | 170.1K | Off |
| 31 Jul 2026 | 6,759 INR | 0.6% | 6,908 INR | 6,690 INR | -0.86 | 3.87 | 127.7K | Off |
| 24 Jul 2026 | 6,720 INR | -5.4% | 6,882 INR | 6,680 INR | -0.81 | 6.03 | 112.4K | On |
| 17 Jul 2026 | 7,102 INR | 1.2% | 6,856 INR | 6,667 INR | -0.77 | 9.64 | 94.0K | On |
| 10 Jul 2026 | 7,021 INR | -2.0% | 6,816 INR | 6,650 INR | -0.69 | 9.14 | 102.6K | On |
| 3 Jul 2026 | 7,166 INR | 2.1% | 6,782 INR | 6,633 INR | -0.70 | 11.27 | 10.9K | On |
| 26 Jun 2026 | 7,022 INR | -5.9% | 6,740 INR | 6,615 INR | -0.68 | 10.28 | 0 | On |
| 19 Jun 2026 | 7,460 INR | 7.9% | 6,705 INR | 6,597 INR | -0.47 | 17.67 | 48.5K | On |
| 12 Jun 2026 | 6,916 INR | -1.3% | 6,655 INR | 6,577 INR | -0.35 | 11.30 | 25.5K | On |
| 5 Jun 2026 | 7,010 INR | -2.7% | 6,616 INR | 6,562 INR | 0.08 | 14.10 | 16.7K | On |
| 29 May 2026 | 7,204 INR | -0.2% | 6,579 INR | 6,542 INR | 0.73 | 16.38 | 211.3K | On |
| 22 May 2026 | 7,222 INR | -1.8% | 6,539 INR | 6,521 INR | 1.09 | 15.85 | 145.1K | On |
| 15 May 2026 | 7,352 INR | -5.8% | 6,502 INR | 6,500 INR | 1.33 | 18.49 | 153.9K | On |
| 8 May 2026 | 7,808 INR | 6.7% | 6,462 INR | 6,478 INR | 1.45 | 23.30 | 575.4K | On |
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.